Biopharmaceutical Engineering
Biopharmaceutical Engineering
Beijing Municipal First-Class Undergraduate Major Construction Site
Modern Industrial College of Biomedicine
Beijing's Strategic Emerging Industry Support Program
Cultivation Objectives
This program aligns with the 14th Five-Year Plan, serving both national and Beijing-Tianjin-Hebei regional economic development needs. It focuses on cultivating high-quality application-oriented talents with:
A solid foundation in biotechnology and pharmacy.
Proficiency in modern biopharmaceutical skills and strong practical abilities.
Good professional ethics, social responsibility, innovative thinking, and communication skills.
Graduates are equipped to engage in product R&D, engineering design, production management, and technical services in the biopharmaceutical industry, contributing to the biomedicine and healthcare industry, which is one of the two innovation-driven growth engines for the nation and the capital.
Cultivation Characteristics
Program Strengths:
Biopharmaceuticals represent a high-tech sunrise industry with promising development potential, recognized as a strategic emerging industry in Beijing. This program is the only engineering program in biopharmaceuticals among universities in Beijing. The program adopts a "3+1" talent cultivation model, including three years of theoretical study on campus followed by one year of practical training in enterprises, enhancing students' competitiveness in the job market. It emphasizes project-based learning, fostering a systematic approach to solving R&D problems while aligning with the master's degree program in Biology and Medicine of the university to support further academic advancement.
Outstanding Faculty:
The program boasts a young, high-level faculty team of 33 full-time teachers, all graduates of prestigious institutions such as Peking University, Tsinghua University, Chinese Academy of Sciences, Nankai University, and University of Wisconsin-Madison.
9 faculty members have received national-level talent honors (e.g., National Thousand Talents Plan).
57.6% of faculty members hold senior professional titles, and 75.8% are under 45 years old.
Over 97% of faculty members hold doctoral degrees.
The team has received numerous teaching and research awards, including the Beijing Teaching Achievement Award (Second Prize), First Prize in Beijing Youth Teacher Teaching Competition, and the China Invention Association Award (Second Prize). In addition, more than 20 enterprise engineers with 80% holding senior professional titles serve as part-time instructors, ensuring close alignment with industry needs through university-enterprise collaboration.
Disciplinary Platforms:
Since its establishment in 2019, the program has developed rapidly, earning the Biology and Medicine Master's Degree Authorization in 2022 and establishing the Modern Industrial College of Biomedicine. In the same year, the program was recognized as a Beijing Municipal First-Class Undergraduate Major Construction Site and included in the 2022 Exemplary Cases of Modern Industrial Colleges.
Relying on national-level industrial parks such as the Beijing E-Town Biomedical Park and the Zhongguancun Daxing Biopharmaceutical Industry Base, as well as the Enze Biomass Fine Chemical Beijing Key Laboratory, the program implements a "industry-education integration, collaborative talent cultivation" model. This ensures excellent teaching and practice conditions for high-quality education.
Innovation and Entrepreneurship:
The program has established education bases in collaboration with the E-Town Biomedical Park and Daxing Biopharmaceutical Base, implementing the "3+1" practical teaching and project-based practice teaching models to cultivate students' innovative thinking and entrepreneurial abilities.
To date, 174 students in the program have demonstrated outstanding performance, earning over 31 provincial or ministerial-level awards in national competitions such as the National Undergraduate Life Science Competition, the American Mathematical Contest in Modeling, and the Internet+ Innovation and Entrepreneurship Competition.
Students have also participated in over 143 school-level and higher practical projects and have secured internships in prestigious biopharmaceutical companies such as Pfizer, receiving widespread praise.
Core Curriculum
Biochemistry, Pharmacology, Pharmaceutics, Cell and Molecular Biology, Microbiology and Immunology, Genetic Engineering, Fermentation and Bioreactor Engineering, Biopharmaceutical Separation Engineering, Biopharmaceutical Analysis, Biopharmaceutical Process Engineering, Biopharmaceutical Equipment and Facility Design, etc.
Postgraduate and International Studies
Domestic Postgraduate Studies:
The program encourages students to pursue postgraduate studies and provides comprehensive guidance for graduate school entrance exams. For the first cohort of graduates in 2023, the graduate school exam pass rate reached 41%. Leading domestic institutions for postgraduate studies include:
China Pharmaceutical University
Shenyang Pharmaceutical University
Beijing University of Chemical Technology
Beijing University of Technology
Institute of Microbiology, Chinese Academy of Sciences
Peking Union Medical College Graduate School
Institute of Materia Medica, Chinese Academy of Medical Sciences
International Studies:
The program has established international cooperation projects with renowned universities, such as:
University of Edinburgh (UK): Offering "4+1," "2+2," and "2+3" collaboration programs.
Heriot-Watt University (UK): Offering a "2+2" dual-degree program.
Students may also participate in exchange programs with institutions such as University of Malaya (QS Ranking 65). These opportunities provide students with a platform to broaden their international perspectives.
Career Prospects and Employment
The biopharmaceutical industry has entered a period of rapid development after years of accumulation, with over 8,200 biopharmaceutical companies in Beijing alone and projected revenues exceeding 300 billion yuan. The industry faces a significant talent gap, with increasing salaries and development opportunities.
Graduates can work in positions related to preclinical research, product R&D, production, marketing, management, and quality control in the biopharmaceutical industry. Employment opportunities include prestigious institutions and enterprises such as:
National Institutes for Food and Drug Control
Beijing Tongrentang Group
Beijing Sinovac Biotech Co., Ltd.
Beijing Minhai Biotechnology Co., Ltd.
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Tian Guangshi Biotechnology Co., Ltd.
Beijing Joinn Laboratories Co., Ltd.
Shenzhou Cell Biotechnology Group Co., Ltd.
Leadman Biochemistry Co., Ltd.
Bio-Thera Solutions
Graduates are well-prepared for further education or professional roles in the biopharmaceutical industry. The program's first graduating cohort in 2023 achieved a 41% graduate school admission rate, demonstrating the program's strong academic foundation and excellent career prospects.